107th Day Of Lockdown

Maharashtra2305991272599667 Tamil Nadu122350741671700 Delhi104864781993213 Gujarat38419273131994 Uttar Pradesh3115620331845 Telangana2953617279324 Karnataka2887711878471 West Bengal2482316291827 Andhra Pradesh2381412154277 Rajasthan2221216877489 Haryana1936414505287 Madhya Pradesh1634112232634 Assam14033872724 Bihar139789792109 Odisha11201740767 Jammu and Kashmir92615567149 Punjab71404945183 Kerala6535370828 Chhatisgarh3526283514 Uttarakhand3305267246 Jharkhand3192217022 Goa203912078 Tripura177313241 Manipur14357930 Puducherry120061916 Himachal Pradesh110182510 Nagaland6733030 Chandigarh5234037 Arunachal Pradesh2871092 Mizoram2031430 Sikkim134710 Meghalaya113451
Lifestyle Health and Wellbeing 19 Oct 2017 New drug discovered ...

New drug discovered to treat bowel cancer by British researchers

ANI
Published Oct 19, 2017, 8:50 am IST
Updated Oct 19, 2017, 8:50 am IST
Most bowel cancers are caused by a mutation in a gene called APC that in its healthy form actually acts to prevent cancer formation.
Mutated APC genes cause excess activity of a cell signalling pathway called 'Wnt', which has been associated with bowel cancer for over 20 years. (Photo: Pexels)
 Mutated APC genes cause excess activity of a cell signalling pathway called 'Wnt', which has been associated with bowel cancer for over 20 years. (Photo: Pexels)

Washington DC: British researchers have recently discovered a new drug target for bowel cancer that is specific to tumour cells and less toxic than conventional therapies to treat the disease.

Most bowel cancers are caused by a mutation in a gene called APC that in its healthy form acts to prevent cancer formation. Mutated APC genes cause excess activity of a cell signalling pathway called 'Wnt', which has been associated with bowel cancer for over 20 years.

 

They found a way to exclusively target 'Wnt' signalling in tumour cells that reduces growth of tumours derived from colon cancer cells without the toxic effects on healthy cells.

First author Laura Novellasdemunt from the Francis Crick Institute---a research institute in London---said that for long there has been a need to find more effective and less toxic drugs to treat bowel cancer.

"We have found a novel drug target that could provide the basis for a better therapy in patients in the future," Novellasdemunt added.

 

Wnt signalling is vital for many organs, so drugs designed to block Wnt signalling in cancer cause very toxic side effects in other parts of the body.

They used the gene-editing tool CRISPR to cut the APC gene at various positions, and found a crucial part of the gene that causes dangerous levels of Wnt signalling and cancer formation.

Using a number of molecular techniques, they identified a protein involved in over activation of the Wnt pathway in cancer.

Preventing the activity of this protein by genetic deletion or blocking it with drugs caused a reduction in Wnt signalling in cancer cells and slowed down tumour growth in mice.

 

Importantly, the drug was found to act exclusively on the tumour cells, and have no effect on Wnt signalling in healthy cells.

The next step will be to see if deleting the gene that makes the protein in mice will prevent them from developing bowel cancer.

This will provide further evidence that the protein is a viable anti-cancer drug target.

The findings are published in Cell Reports.

...




ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT